| 000 | 01760 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250516084400.0 | ||
| 264 | 0 | _c20121108 | |
| 008 | 201211s 0 0 eng d | ||
| 022 | _a1523-4681 | ||
| 024 | 7 |
_a10.1002/jbmr.1613 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBlock, Geoffrey A | |
| 245 | 0 | 0 |
_aA single-dose study of denosumab in patients with various degrees of renal impairment. _h[electronic resource] |
| 260 |
_bJournal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research _cJul 2012 |
||
| 300 |
_a1471-9 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntibodies, Monoclonal, Humanized _xpharmacokinetics |
| 650 | 0 | 4 | _aArea Under Curve |
| 650 | 0 | 4 |
_aCalcium _xmetabolism |
| 650 | 0 | 4 |
_aCalcium Gluconate _xmetabolism |
| 650 | 0 | 4 |
_aCollagen Type I _xblood |
| 650 | 0 | 4 | _aDenosumab |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGlomerular Filtration Rate _xdrug effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aKidney _xmetabolism |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aPeptides _xblood |
| 650 | 0 | 4 | _aRenal Dialysis |
| 650 | 0 | 4 |
_aRenal Insufficiency _xdrug therapy |
| 650 | 0 | 4 | _aUnited States |
| 650 | 0 | 4 | _aUnited States Food and Drug Administration |
| 650 | 0 | 4 |
_aVitamin D _xmetabolism |
| 700 | 1 | _aBone, Henry G | |
| 700 | 1 | _aFang, Liang | |
| 700 | 1 | _aLee, Edward | |
| 700 | 1 | _aPadhi, Desmond | |
| 773 | 0 |
_tJournal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research _gvol. 27 _gno. 7 _gp. 1471-9 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1002/jbmr.1613 _zAvailable from publisher's website |
| 999 |
_c21663868 _d21663868 |
||